Literature DB >> 10365820

Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats.

N Assy1, G Spira, M Paizi, L Shenkar, Y Kraizer, T Cohen, G Neufeld, B Dabbah, R Enat, Y Baruch.   

Abstract

BACKGROUND/AIMS: Vascular endothelial growth factor (VEGF) is an angiogenic factor with a growth-promoting effect that is thought to be restricted to vascular endothelial cells. Its essential role during liver regeneration has yet to be determined. The aim of this study was to document the effect of exogenous VEGF administration on liver regeneration in rats undergoing submaximal hepatic resections.
METHODS: Adult male Sprague-Dawley rats (n = 4/group) undergoing 30% partial hepatectomy were administered 200 ng VEGF165 intravenously and were sacrificed at 24, 36, and 48 h postoperatively. Liver regeneration was monitored by measuring the restituted liver mass, proliferating cell nuclear antigen (PCNA) immunostaining, and hepatic PCNA protein by Western blot.
RESULTS: Changes in restituted liver mass 48 h postsurgery were more prominent, but did not differ statistically between VEGF-treated and control rats (47% vs. 29%; p<0.06). Nevertheless, PCNA immunostaining showed increased labeling index of hepatocytes, apparent at 36 and 48 h after partial hepatectomy (38% vs. 18% [p<0.041 and 42% vs. 11% [p<0.021], respectively). Hepatic PCNA proteins measured by Western blot showed a 3-fold increase in VEGF-treated rats 48 h postsurgery compared with controls (p<0.01).
CONCLUSION: Exogenous VEGF administration early after partial hepatectomy stimulates liver regeneration in rats. Whether or not VEGF165 is a direct mitogen for hepatocytes remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365820     DOI: 10.1016/s0168-8278(99)80147-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  19 in total

1.  Protective effects of ACLF sera on metabolic functions and proliferation of hepatocytes co-cultured with bone marrow MSCs in vitro.

Authors:  Xiao-Lei Shi; Jin-Yang Gu; Yue Zhang; Bing Han; Jiang-Qiang Xiao; Xian-Wen Yuan; Ning Zhang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Vascular endothelial growth factor and angiopoietins regulate sinusoidal regeneration and remodeling after partial hepatectomy in rats.

Authors:  Hiroaki Shimizu; Noboru Mitsuhashi; Masayuki Ohtsuka; Hiroshi Ito; Fumio Kimura; Satoshi Ambiru; Akira Togawa; Hiroyuki Yoshidome; Atsushi Kato; Masaru Miyazaki
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 3.  Endothelium as master regulator of organ development and growth.

Authors:  Daniela Tirziu; Michael Simons
Journal:  Vascul Pharmacol       Date:  2008-09-05       Impact factor: 5.773

Review 4.  Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases.

Authors:  De-Bang Li; Feng Ye; Xiu-Rong Wu; Lu-Peng Wu; Jing-Xi Chen; Bin Li; Yan-Ming Zhou
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

5.  Endothelial-directed hepatic regeneration after partial hepatectomy.

Authors:  Arin K Greene; Stephen Wiener; Mark Puder; Atsushi Yoshida; Bin Shi; Antonio R Perez-Atayde; Jason A Efstathiou; Lars Holmgren; Anthony P Adamis; Maria Rupnick; Judah Folkman; Michael S O'Reilly
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

6.  Insulin promotes sinusoidal endothelial cell proliferation mediated by upregulation of vascular endothelial growth factor in regenerating rat liver after partial hepatectomy.

Authors:  Jian-Guo Qiao; Long Wu; Dao-Xiong Lei; Lu Wang
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

7.  Hepatic stellate cells produce vascular endothelial growth factor via phospho-p44/42 mitogen-activated protein kinase/cyclooxygenase-2 pathway.

Authors:  Yi Zhao; Yanqing Wang; Qiang Wang; Zhengrong Liu; Qingfeng Liu; Xin Deng
Journal:  Mol Cell Biochem       Date:  2011-08-24       Impact factor: 3.396

8.  A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levels.

Authors:  Richard J Aspinall; Sara M Weis; Leo Barnes; Kimberly Lutu-Fuga; David J Bylund; Paul J Pockros; David A Cheresh
Journal:  Liver Int       Date:  2011-06-07       Impact factor: 5.828

9.  Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.

Authors:  Nicole L Ward; Alexandra L Haninec; Paul Van Slyke; John G Sled; Celina Sturk; R Mark Henkelman; Ian R Wanless; Daniel J Dumont
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

10.  The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failure.

Authors:  Tadashi Namisaki; Hitoshi Yoshiji; Ryuichi Noguchi; Yasuhide Ikenaka; Mitsuteru Kitade; Kosuke Kaji; Yusaku Shirai; Yosuke Aihara; Junichi Yoshii; Koji Yanase; Tatsuhiro Tsujimoto; Hideto Kawaratani; Hiroshi Fukui
Journal:  J Angiogenes Res       Date:  2010-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.